Biosimilars Ready, at Last, to make their Entrance: Stars Are Born or do they Fizzle?

Reinke, T.

Managed Care 26(3): 20-23

2017


ISSN/ISBN: 1062-3388
PMID: 28510515
Document Number: 692504
The future of biosimilars in this country is nothing if not uncertain. Most immediately, the U.S. Supreme Court is hearing a case that will determine the timing of the 180-day waiting period before a biosimilar can go on the market. But there are larger and longer-term issues at play as well.

Document emailed within 1 workday
Secure & encrypted payments